Compugen (CGEN) Cash from Financing Activities (2009 - 2010)

Compugen (CGEN) reported Cash from Financing Activities of $890000.0 for Q4 2010, down 92.65% on a YoY basis from $12.1 million in Q4 2009, and up 947.06% sequentially from $85000.0 in Q3 2010.

Compugen (CGEN) Cash from Financing Activities (2009 - 2010) Analysis & Trends

Compugen (CGEN) has 2 years of Cash from Financing Activities data on file, last reported at $890000.0 in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Compugen 221.26 Mn 129.51 Mn 352,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2010 890,000.00
Dec 31, 2010 890,000.00
Sep 30, 2010 85,000.00
Sep 30, 2010 85,000.00
Dec 31, 2009 12.10 Mn
Dec 31, 2009 12.10 Mn